15 min listen
Review of the Clarity Study
ratings:
Length:
23 minutes
Released:
Oct 23, 2017
Format:
Podcast episode
Description
Dr. Amin Kherani discusses the Clarity study which compares use of intravitreal aflibercept injections versus PRP laser for proliferative diabetic retinopathy. We also briefly discuss DRCR.net protocol S results that compare intravitreal ranibizumab versus PRP laser for the same indication. Full reference of the Clarity article: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Sivaprasad, SobhaBhatnagar, A et al. The Lancet , Volume 389 , Issue 10085 , 2193 - 2203 DOI:10.1016/S0140-6736(17)31193-5
Released:
Oct 23, 2017
Format:
Podcast episode
Titles in the series (76)
E15-Serum VEGF Levels in the IVAN Trial- Dr. Usha Chakravarthy: Dr. Chakravarthy from Belfast, UK discusses a secondary analysis of the IVAN Trial to compare effects of intravitreal anti-VEGF therapy on serum VEGF levels with possible trends in system adverse events in the context of wet AMD. Full reference: Chris... by The Retina Channel Podcast